검색어 : 통합검색[Berry Walter]
총 404건 중 404건 출력
, 41/41 페이지
-
401
- Large anomalous Hall effect driven by a nonvanishing Berry curvature in the noncolinear antiferromagnet Mn <sub>3</sub> Ge
- Nayak, Ajaya K.; Fischer, Julia Erika; Sun, Yan; Yan, Binghai; Karel, Julie; Komarek, Alexander C.; Shekhar, Chandra; Kumar, Nitesh; Schnelle, Walter; Kü bler, Jü rgen; Felser, Claudia; Parkin, Stuart S. P.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Max Planck Institute for Chemical Physics of Solids, Nö thnitzer Str. 40, 01187 Dresden, Germany.; Institut fü r Festkö rperphysik, Technische Universit&au; (Science advances, v.2, 2016, pp.e1501870)
-
402
- Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with <i>Plasmodium falciparum</i> apical membrane antigen 1 vaccine candidate FMP2.1/AS02 <sub>A</sub>
- Berry, Andrea A.; Gottlieb, Eric R.; Kouriba, Bourema; Diarra, Issa; Thera, Mahamadou A.; Dutta, Sheetij; Coulibaly, Drissa; Ouattara, Amed; Niangaly, Amadou; Kone, Abdoulaye K.; Traore, Karim; Tolo, Youssouf; Mishcherkin, Vladimir; Soisson, Lorraine; Diggs, Carter L.; Blackwelder, William C.; Laurens, Matthew B.; Sztein, Marcelo B.; Doumbo, Ogobara K.; Plowe, Christopher V.; Lyke, Kirsten E.; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD USA; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD USA; University of Sciences, Techniques, and Technologies, Bamako, Bamako, Mali; University of Sciences, Techniques, and Technologies, Bamako, Bamako, Mali; University of Sciences, Techniques, and Technologies, Bamako, Bamako, Mali; Walter Reed Army Institute of Research, Silver Spring, MD USA; University of Sciences, Techniques, and Technologies, Bamako, Bamako, Mali; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD USA; University of Sciences, Techniques, and Technologies, Bamako, Bamako, Mali; University of Sciences, Techniques, and Technologies, Bamako, Bamako, Mali; University of Sciences, Techniques, and Technologies, Bamako, Bamako, Mali; University of Sciences, Techniques, and Technologies, Bama; (Malaria journal, v.18, 2019, pp.13)
-
403
- Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients
- Brown, Tommy A.; Byrd, Kevin; Vreeland, Timothy J.; Clifton, Guy T.; Jackson, Doreen O.; Hale, Diane F.; Herbert, Garth S.; Myers, John W.; Greene, Julia M.; Berry, John S.; Martin, Jonathan; Elkas, John C.; Conrads, Thomas P.; Darcy, Kathleen M.; Hamilton, Chad A.; Maxwel, George L.; Peoples, George E.; Department of Surgery San Antonio Military Medical Center San Antonio Texas; National Capital Consortium Fellowship in Gynecologic Oncology Walter Reed National Military Medical Center Bethesda Bethesda Maryland; Department of Surgical Oncology The University of Texas MD Anderson Cancer Center Houston Texas; Department of Surgery San Antonio Military Medical Center San Antonio Texas; Department of Surgery San Antonio Military Medical Center San Antonio Texas; Department of Surgery San Antonio Military Medical Center San Antonio Texas; Department of Surgery San Antonio Military Medical Center San Antonio Texas; Department of Surgery San Antonio Military Medical Center San Antonio Texas; Department of Surgery San Antonio Military Medical Center San Antonio Texas; Department of Surgery Womack Army Medical Center Fayetteville North Carolina; Cancer Vaccine Development Program San Antonio Texas; Department of Obstetrics and Gynecology Inova Fairfax Hospital Annandale Virginia; N; (Cancer medicine, v.8, 2019, pp.4678-4687)
-
404
- Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
- Jackson, Doreen O.; Byrd, Kevin; Vreeland, Timothy J.; Hale, Diane F.; Herbert, Garth S.; Greene, Julia M.; Schneble, Erika J.; Berry, John S.; Trappey, Alfred F.; Travis Clifton, Guy; Hardin, Mark O.; Martin, Jonathan; Elkas, John C.; Conrads, Thomas P.; Darcy, Kathleen M.; Hamilton, Chad A.; Maxwell, George L.; Peoples, George E.; Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USA; National Capital Consortium Fellowship in Gynecologic Oncology, Walter Reed National Military Medical Center Bethesda, MD, USA; Department of Surgery, Womack Army Medical Center, Fayetteville, NC, USA; Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USA; Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USA; Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USA; Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USA; Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USA; Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Surgery, Madigan Army Medical Center, Tacoma, WA, USA; Cancer Vaccine Development Program, San An; (Oncotarget, v.8, 2017, pp.15912-15923)
41
QUICK MENU
